WASHINGTON, Sept 14 (Reuters) - Obagi Medical Products Inc OMPI.O filed with regulators on Friday for an offering of up to $100 million of its common stock. The company, which develops prescription skin care products, said in a …
Obagi Medical (OMPI): Shares are hoisted to Buy from Hold at Cantor Fitzgerald ... VMware (VMW): S&P Capital IQ takes the tech stock to Buy from Hold. (See also: New Stock Coverage: Money Trees Growing in Forest City and Stock
The stock is now up 18.69% to $16.93 after creating a new 52-week ... at the JMP Securities failed to defend the recent …
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now. Obagi Medical Products (NASDAQ: OMPI): Current price $25.42 Obagi’s board has received a letter from Merz Pharma Group, which …
In a letter to the Board of Directors of Obagi Medical Products, Inc. (NASDAQ: OMPI) Merz Pharma Group today outlined a proposal to acquire all of the outstanding common stock of Obagi for $22 per share in cash. This proposal represents …
Among the companies with shares expected to actively trade in Tuesday’s session are BGC Partners Inc. (BGCP), Obagi Medical Products Inc. (OMPI) and Humana Inc. (HUM ... eSpeed platform from BGC in a cash-and-stock deal worth as …
At $34.95, the stock price has risen 9.5%. The stock has moved up across its 50-day moving average of $34.76 today. Obagi Medical Products (OMPI) is up on high volume today, trading with volume of 1.3 million, or 2.3 times its average …
Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are delayed by at …
Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (VRX) announced Wednesday that it's buying skin-cream maker Obagi Medical Products (OMPI) for $344 million, sending both shares up in the stock market today. …